Susan Hasty, Publisher
Table of Contents . . . December 8th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Clinical Trials - Challenges of recruitment and retention in multisite clinical research
Heart Attack - TP10 complement inhibitor decreases heart attacks, death
Atrial Fibrillation - Positive phase II selodenoson data presented
Oncology Trials - Clinical trials in pediatric cancer: Parental perspectives on informed consent
Reproductive Medicine - Nitric oxide donors don't improve cervical ripening before induced abortion
Aging - Testosterone research strategies outlined by IOM
Allergy - Astelin effective in patients whose allergies respond inadequately to Allegra
Angina - Blood-thinning agent may be better than heparin
Angina - Significant benefits of TMR demonstrated over drug therapy
Asthma - Long-term Aerospan treatment has no effect on growth in mildly asthmatic children
Atherosclerosis - Lipitor reduces progression of atherosclerosis in new study
Atrial Fibrillation - Arctic Circler highlighted at heart association meeting
Attention Deficit Hyperactivity Disorder - Girls lack of hyperactivity may lead to under-diagnosis
Blood Cancer - Data presented on Revimid in malignant blood disorders
Brain Cancer - AP23573 potently blocks brain tumor cell growth
Breast Cancer - Imaging technique may enable diagnosis without biopsy
Cancer Care - Partnership provides leading-edge care to under-served Los Angeles residents
Cancer Therapy - CCI-779 prevents abnormal brain cell growth and reverses seizures in lab mice
Cardiovascular Disease - Cholesterol in skin helps identify hidden cardiovascular disease
Colon Cancer - Modified de Gramont with oxaliplatin in treatment of advanced colorectal cancer
Congestive Heart Failure - First implantation of unique cardioverter defibrillator reported
Congestive Heart Failure - Positive phase II trial results reported on Adentri
Coronary Artery Bypass - Results of phase III PRIMO-CABG trial presented
Coronary Artery Disease - Details on third CardioPass patient released, phase II trials started
Coronary Artery Disease - Landmark trial in coronary atherosclerosis concluded
Corporate Update - Antipathogen company moves toward clinical trials, engages GunnAllen Financial
Drug Delivery - Dosing completed in phase III trials of Metformin, Ciprofloxacin
Drug Delivery - Trial demonstrates successful delivery of obesity drug nasal spray
Drug Review - FDA's fast track initiative cut development time by 3 years
Finance - Immune disorders drug maker reports loss of $0.01 per share
Finance - Prestara maker reports increased losses, decreased revenues, in third quarter
Glomerulonephritis - CYC202 has beneficial effects in kidney disease models
Glucose Control - Exenatide continues to generate positive results in second phase III study
Head and Neck Cancer - Advanced head and neck cancer drug being evaluated in phase I trial
Heart Attack - Antiplatelet drug found to reduce risk of recurrent heart attacks, stroke
Heart Attack - Drug proven to benefit heart attack victims is vastly underused
Heart Attack - Trial to evaluate TNKase/Metalyse use prior to angioplasty
Heart Disease - Cilostazol reduces coronary artery stent restenosis by 40%
Heart Pumps - Site selection nears completion for trial of DeBakey VAD for destination therapy
Hematology - Single agent thalidomide won't help those with relapsed acute myeloid leukemia
Hepatitis C VIrus - Safety trial initiated for experimental hepatitis C drug treatment
Inflammation - Pathway found implicating superoxide as important mediator of inflammatory pain
Insomnia - FDA extends PDUFA action date for Estorra NDA
Insulin Research - Company to reacquire rights and data from alliance on modified insulin products
Japanese Encephalitis - Chimeric attenuated vaccine protects against Japanese encephalitis
Kidney Disease - Research program to study effects of D-Receptor activation
Leukemia - Positive Dacogen data presented at chemotherapy conference
Leukemia Therapy - In AML patients, pretransplant MRD status predicts auto-SCT outcome
Limb Ischemia - Data reported from gene therapy using engineered form of the HIF-1alpha
Lung Cancer - Weekly carboplatin and paclitaxel in elderly non-small cell lung cancer patients
Macular Degeneration - New anecortave acetate clinical trials initiated
Market Analysis - Clinical trial communication plans can be helped with toolkit
Melanoma - Genasense may improve activity of anticancer therapy
Myocardial Infarction - Study: Newer formulation of heparin improves outcomes
Non-Hodgkin Lymphoma - Phase III trial of Rituxan maintenance reaches efficacy endpoint early
Obesity Therapy - Oxyntomodulin suppresses appetite and reduces food intake in humans
Otitis Media - 7-Valent pneumococcal conjugate vaccine effective against otitis media
Ovarian Cancer - A phase II trial of bryostatin-I in recurrent epithelial ovarian carcinoma
Pain Therapy - Approval granted for phase II trial of AeroLEF
Patents - Patent office allows additional patent claims to STR for cancer therapy
Postoperative Ileus - Enrollment completed in phase III study 308 of Entereg
Premature Birth - U.S. study initiated in pregnant women at high risk of preterm delivery
Prostate Cancer - Improving quality of life in men with prostate cancer
Prostate Cancer - Phase III trial of Acapodene initiated for the treatment of androgen deprivation
Prostate Cancer - Pivotal Eligard 45-mg phase III clinical study
Prostate Cancer - Provenge phase III data shows extended survival time
Pulmonary Arterial Hypertension - Pulmonary arterial hypertension treatment data shows prolonged survival
Renal Disease - At-home dialysis an effective option for more patients
Rheumatoid Arthritis - Phase IIb clinical trials of Pralnacasan discontinued due to toxicity
Rheumatoid Arthritis - Positive data reported on rheumatoid arthritis treatment study
Thoracic Aneurysms - Talent Thoracic Stent Graft study begins
Translational Research - New strategy aims to make U.K. bioscience sector a world beater
Uveitis - Drug delivery technology for ophthalmology applications presented
Vertebral Compression Fractures - FDA grants investigational device exemption for bone void filler clinical study
Wound Healing - Study results indicate Oasis may be "more likely to heal"
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.